Description

[(1S,4Ar,7S)-1,4A,5,6,7,7A-Hexahydro-5α,6α,7α-Trihydroxy-7-[[[(E)-1-Oxo-3-Phenyl-2-Propenyl]Oxy]Methyl]Cyclopenta[C]Pyran-1-Yl]β-D-Glucopyranoside is a complex glycosidic compound of significant interest in advanced organic synthesis and pharmaceutical research. This molecule is valued for its intricate stereochemistry and functional groups, which serve as a versatile scaffold for developing novel bioactive compounds. It is primarily sought by research institutions and pharmaceutical companies engaged in the discovery and development of new therapeutic agents, particularly in areas requiring sophisticated chiral intermediates.

Application

• Pharmaceutical Intermediate: Serves as a key chiral building block in the synthesis of novel drug candidates, especially for complex small-molecule therapeutics.
• Medicinal Chemistry Research: Used as a reference standard or a starting material for structure-activity relationship (SAR) studies and lead optimization.
• Biochemical Research: Employed in enzymatic and receptor-binding studies due to its glycosidic nature and specific stereoconfiguration.
• Process Development: Acts as a critical intermediate for scaling up synthetic routes in process chemistry within GMP environments.
• Academic Research: Utilized in universities and research institutes for studies in synthetic organic chemistry, glycoscience, and natural product analog synthesis.

Basic Information

Product Name	[(1S,4Ar,7S)-1,4A,5,6,7,7A-Hexahydro-5α,6α,7α-Trihydroxy-7-[[[(E)-1-Oxo-3-Phenyl-2-Propenyl]Oxy]Methyl]Cyclopenta[C]Pyran-1-Yl]β-D-Glucopyranoside
CAS No.	73343-11-0
Molecular Formula	C24H30O12
Molecular Weight	510.49 g/mol
Synonyms	7-[[(E)-Cinnamoyloxy]methyl]hexahydro-5α,6α,7α-trihydroxycyclopenta[c]pyran-1-yl β-D-glucopyranoside; Cinnamoyl Glucose Derivative; (1S,4aR,7S)-1,4a,5,6,7,7a-Hexahydro-5,6,7-trihydroxy-7-[[[(1E)-3-phenyl-1-oxo-2-propen-1-yl]oxy]methyl]cyclopenta[c]pyran-1-yl β-D-glucopyranoside; CAS 73343-11-0; Glucopyranoside derivative of cinnamic acid; Cyclopenta[c]pyran glucoside cinnamate.
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. We provide comprehensive analytical data, including HPLC, NMR, and MS, to verify identity and purity. Certificates of Analysis (COA) are available upon request, detailing batch-specific results. Our quality management system supports the needs of research and development, with the capability to supply material under GMP-grade conditions for advanced pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.